
About WEHI
WEHI was established in 1915 as a research laboratory dedicated to medical investigations. Focus is placed on disease detection through scientific studies in the biomedical sector. Operations involve collaborative projects aimed at advancing diagnostic methods and treatments. Services include research partnerships and data analysis for health advancements. Activities are based in the United States, supporting global health initiatives.
- Latest Funding Round$1.6M (USD), Grant
Jul 2014
- Investors
Apps and channels of WEHI
its YouTube channel WEHImovies has 4.34K subscribers and 30 videos.
Videos from WEHI
The most watched videos on WEHI's YouTube channel, WEHImovies (4.34K subscribers). Click a video to play it here.
More on WEHImovies.
Funding Insights of WEHI
- Total Rounds 8
- Last Round Grant β $1.6M
- First Round $405,723
(Mar 2007)
- Investors Count 1
All 8 funding rounds of WEHI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in WEHI
WEHI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for WEHI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of WEHI
72 people are tracked at WEHI (48 in leadership, 14 in board & advisors, 10 in team).
| Name | Role | Group |
|---|---|---|
Helene Martin | Head, Laboratory Operations | Leadership |
Robert Trainor | Head, Facilities | Leadership |
Peter Gibbs | Division Head, Laboratory Head | Leadership |
Wai-Hong Tham | Division Head, Infectious Diseases & Immune Defence | Leadership |
Sant-Rayn Pasricha | Division Head, Population Health & Immunity | Leadership |
Deborah Carr | Head of Philanthropy | Leadership |
Melissa Call | Laboratory Head | Leadership |
Ivo Mueller | Division Head, Laboratory Head | Leadership |
Marie-Liesse Asselin-Labat | Division Head, Personalised Oncology | Leadership |
Naiyang Fu | Laboratory Head | Leadership |
Michael Lazarou | Head Of Laboratory | Leadership |
Vanessa Bryant | Laboratory Head | Leadership |
Marija Dramicanin | Head, Protein Production Facility | Leadership |
Marie-Liesse Labat | Division Head | Leadership |
Anne Voss | Division Head, Epigenetics & Development | Leadership |
Chela Niall | Head, Legal, Research & Business Development | Leadership |
Yunshun Chen | Laboratory Head | Leadership |
Kelly Rogers | Division Head, Laboratory Head | Leadership |
Alistair Brown | CFO | Leadership |
Lindsay Karakiozakis | Chief People Officer | Leadership |
52 more people are available in the full profile.
Complete people profiles for WEHI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of WEHI
3 dated milestones of WEHI across 99 years, from founding to its latest funding, stage changes and deals.
- Founded WEHI is founded.
- Funding First funding round of $406K.
- Funding Latest funding round, Grant, of $1.6M.
Web traffic of WEHI
The website of WEHI (wehi.edu.au) receives about 102.9K visits a month.
- Monthly visits102.9K
▲ 34.4% vs previous month
Websites whose visitors overlap most with WEHI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| csiro.au | 100% | 664.4K | #88,935 | View details | |
sciblogs.co.nz | sciblogs.co.nz | 100% | – | – | β |
blogs.plos.org | blogs.plos.org | 100% | – | – | β |
wehieduau.sharepoint.com | wehieduau.sharepoint.com | 97% | – | – | β |
| akoyabio.com | 94% | 23K | #1,213,479 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 37 similar websites and full traffic analytics for WEHI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 37 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to WEHI
10 companies that operate in the same segment as WEHI (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about WEHI
WEHI was founded in 1915 and raised its 1st funding round 92 years after it was founded.
WEHI is headquartered in United States.
WEHI was established in 1915 as a research laboratory dedicated to medical investigations. Focus is placed on disease detection through scientific studies in the biomedical sector. Operations involve collaborative projects aimed at advancing diagnostic methods and treatments. Services include research partnerships and data analysis for health advancements. Activities are based in the United States, supporting global health initiatives.
WEHI has 1 investor. Key investors include HHS.
WEHI operates through The Walter And Eliza Hall Institute Of Medical Research.
The website of WEHI receives about 103 thousand visits a month.